FdaApplication

ANDA 211353

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2022-01-27

Products (1)

ProductActive ingredientStrengthDosage form
SOFOSBUVIRSOFOSBUVIR400MGTABLET;ORAL

1 product